fivenewscrypto
Terkini Populer Kategori
Headline
Loading...

Technology

[Technology][recentbylabel]

Ads Auto

jeudi 20 novembre 2025

Tech giants pour billions into Anthropic as circular AI investments roll on

Tech giants pour billions into Anthropic as circular AI investments roll on

On Tuesday, Microsoft and Nvidia announced plans to invest in Anthropic under a new partnership that includes a $30 billion commitment by the Claude maker to use Microsoft’s cloud services. Nvidia will commit up to $10 billion to Anthropic and Microsoft up to $5 billion, with both companies investing in Anthropic’s next funding round.

The deal brings together two companies that have backed OpenAI and connects them more closely to one of the ChatGPT maker’s main competitors. Microsoft CEO Satya Nadella said in a video that OpenAI “remains a critical partner,” while adding that the companies will increasingly be customers of each other.

“We will use Anthropic models, they will use our infrastructure, and we’ll go to market together,” Nadella said.

Read full article

Comments

Microsoft tries to head off the “novel security risks” of Windows 11 AI agents

Microsoft tries to head off the “novel security risks” of Windows 11 AI agents

Microsoft has been adding AI features to Windows 11 for years, but things have recently entered a new phase, with both generative and so-called “agentic” AI features working their way deeper into the bedrock of the operating system. A new build of Windows 11 released to Windows Insider Program testers yesterday includes a new “experimental agentic features” toggle in the Settings to support a feature called Copilot Actions, and Microsoft has published a detailed support article detailing more about just how those “experimental agentic features” will work.

If you’re not familiar, “agentic” is a buzzword that Microsoft has used repeatedly to describe its future ambitions for Windows 11—in plainer language, these agents are meant to accomplish assigned tasks in the background, allowing the user’s attention to be turned elsewhere. Microsoft says it wants agents to be capable of “everyday tasks like organizing files, scheduling meetings, or sending emails,” and that Copilot Actions should give you “an active digital collaborator that can carry out complex tasks for you to enhance efficiency and productivity.”

But like other kinds of AI, these agents can be prone to error and confabulations and will often proceed as if they know what they’re doing even when they don’t. They also present, in Microsoft’s own words, “novel security risks,” mostly related to what can happen if an attacker is able to give instructions to one of these agents. As a result, Microsoft’s implementation walks a tightrope between giving these agents access to your files and cordoning them off from the rest of the system.

Read full article

Comments

The Analogue 3D is the modern N64 fans have been waiting for

The Analogue 3D is the modern N64 fans have been waiting for

If you’ve ever tried to hook an old Nintendo 64 up to a modern HDTV, you know the results can be less than ideal. Assuming your original hardware still works and your flatscreen even has the requisite R/F and/or composite inputs to allow for the connection, the N64’s output will probably look like a blurry mess on a flatscreen that wasn’t designed with those old video signals as a priority.

The Analogue 3D solves this very specific problem very well, with a powerful FPGA core that accurately replicates a Nintendo 64 and well-made display filters that do a good job of approximating that cathode-ray tube glow you remember from decades ago. But the lack of easy expandability limits the appeal of this $250 device to all but the most die-hard fans of original N64 hardware.

A beauty to behold

As a piece of physical design, the Analogue 3D is a work of art. The gentle curves of its sleek black shell evoke the original N64 design without copying it, coming in at a slightly smaller footprint and height. Plus, there’s no ugly power brick.

Read full article

Comments

mercredi 19 novembre 2025

Bonkers Bitcoin heist: 5-star hotels, cash-filled envelopes, vanishing funds

Bonkers Bitcoin heist: 5-star hotels, cash-filled envelopes, vanishing funds

As Kent Halliburton stood in a bathroom at the Rosewood Hotel in central Amsterdam, thousands of miles from home, running his fingers through an envelope filled with 10,000 euros in crisp banknotes, he started to wonder what he had gotten himself into.

Halliburton is the cofounder and CEO of Sazmining, a company that operates bitcoin mining hardware on behalf of clients—a model known as “mining-as-a-service.” Halliburton is based in Peru, but Sazmining runs mining hardware out of third-party data centers across Norway, Paraguay, Ethiopia, and the United States.

As Halliburton tells it, he had flown to Amsterdam the previous day, August 5, to meet Even and Maxim, two representatives of a wealthy Monaco-based family. The family office had offered to purchase hundreds of bitcoin mining rigs from Sazmining—around $4 million worth—which the company would install at a facility currently under construction in Ethiopia. Before finalizing the deal, the family office had asked to meet Halliburton in person.

Read full article

Comments

Trump admin axed 383 active clinical trials, dumping over 74K participants

Trump admin axed 383 active clinical trials, dumping over 74K participants

When the Trump administration brutally cut federal funding for biomedical research earlier this year, at least 383 clinical trials that were already in progress were abruptly canceled, cutting off over 74,000 trial participants from their experimental treatments, monitoring, or follow-ups, according to a study published today in JAMA Internal Medicine.

The study, led by researchers at Harvard, fills a knowledge gap of how the Trump administration’s research funding cuts affected clinical trials specifically. It makes clear not just the wastefulness and inefficiency of the cuts but also the deep ethical violations, JAMA Internal Medicine editors wrote in an accompanying editor’s note.

In March, the National Institutes of Health, under the control of the Trump administration, announced that it would cancel $1.8 billion in grant funding that wasn’t aligned with the administration’s priorities. The Harvard researchers, led by health care policy expert Anupam Jena, used an NIH database and a federal accountability tracking tool to find grants supporting clinical trials that were active as of February 28 but had been terminated by August 15.

Read full article

Comments

With a new company, Jeff Bezos will become a CEO again

With a new company, Jeff Bezos will become a CEO again

Jeff Bezos is one of the world’s richest and most famous tech CEOs, but he hasn’t actually been a CEO of anything since 2021. That’s now changing as he takes on the role of co-CEO of a new AI company, according to a New York Times report citing three people familiar with the company.

Grandiosely named Project Prometheus (and not to be confused with the NASA project of the same name), the company will focus on using AI to pursue breakthroughs in research, engineering, manufacturing, and other fields that are dubbed part of “the physical economy”—in contrast to the software applications that are likely the first thing most people in the general public think of when they hear “AI.”

Bezos’ co-CEO will be Vik Bajaj, a chemist and physicist who previously led life sciences work at Google X, an Alphabet-backed research group that worked on speculative projects that could lead to more product categories. (For example, it developed technologies that would later underpin Google’s Waymo service.) Bajaj also worked at Verily, another Alphabet-backed research group focused on life sciences, and Foresite Labs, an incubator for new AI companies.

Read full article

Comments

Judge smacks down Texas AG’s request to immediately block Tylenol ads

Judge smacks down Texas AG’s request to immediately block Tylenol ads

A Texas Judge has rejected a request from Texas Attorney General Ken Paxton to issue a temporary order barring Tylenol’s maker, Kenvue, from claiming amid litigation that the pain and fever medication is safe for pregnant women and children, according to court documents.

In records filed Friday, District Judge LeAnn Rafferty, in Panola County, also rejected Paxton’s unusual request to block Kenvue from distributing $400 million in dividends to shareholders later this month.

The denials are early losses for Paxton in a politically charged case that hinges on the unproven claim that Tylenol causes autism and other disorders—a claim first introduced by President Trump and his anti-vaccine health secretary, Robert F. Kennedy Jr.

Read full article

Comments

Ads Auto


Smartphones

[Smartphones][recentbylabel]

Ads Auto

Photography

[Photography][recentbylabel2]

Economy

[Economy][recentbylabel2]